Pediatric patients with sickle cell anemia and a history of abnormal cerebral artery velocities had reduced hospitalizations ...

A phase 3 trial confirms “the potent anti-leukemic effect” of consolidation with allogeneic transplant in older patients with acute myeloid leukemia, according to researchers.

ALLO Fiber has announced construction will soon begin this spring on a network build in the city of Boulder, Colorado.

Allo.xyz, a platform specializing in real-world asset (RWA) tokenization and lending, has secured a landmark $100 million ...

Two posters presented at the 2024 American Society of Hematology meeting reported real-world outcomes data for patients ...

Allogene Therapeutics (ALLO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Allogene Therapeutics Inc (ALLO) stock saw a decline, ending the day at $2.16 which represents a decrease of $-0.04 or -1.82% from the prior close of $2.2. The stock opened at $2.21 and touched a low ...

Investors might want to bet on Allogene Therapeutics (ALLO), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...

UAE-based Allo.xyz, a platform for real-world asset (RWA) tokenization and lending, has secured a $100 million Bitcoin-backed ...

Allogene Therapeutics Inc (ALLO) stock saw a modest uptick, ending the day at $2.13 which represents a slight increase of $0.03 or 1.43% from the prior close of $2.1. The stock opened at $2.14 and ...

Allo Communications LLC, a Lincoln, Nebraska-based telecommunications company, plans to build a fiber-optic broadband network ...